Drug, Biotech Firms Beginning To Embrace Combinatorial Chemistry

Combinatorial Chemistry An emerging chemical discovery method is proving to be a fruitful source of research and job opportunities. The technique-called combinatorial chemistry-has spawned a wave of in-house pharmaceutical research and new collaboration between drug firms and biotech companies. Similar programs may also be on the horizon for agrochemical and materials science researchers. EUREKA: Ronald Zuckerman recalls Chiron's success Combinatorial chemistry shifts compound design from a

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Combinatorial Chemistry An emerging chemical discovery method is proving to be a fruitful source of research and job opportunities. The technique-called combinatorial chemistry-has spawned a wave of in-house pharmaceutical research and new collaboration between drug firms and biotech companies. Similar programs may also be on the horizon for agrochemical and materials science researchers.


EUREKA: Ronald Zuckerman recalls Chiron's success
Combinatorial chemistry shifts compound design from a one-molecule-at-a-time approach to automated parallel synthesis. Starting with a useful compound or molecule, chemists can use robotics to spin that "lead" into thousands-or hundreds of thousands-of chemical variations. The resulting chemical diversity boosts the chance that a new compound will usefully react with a molecular target-say, a disease-causing molecule.

Drug and agrochemical industry leaders predict combinatorial chemistry will speed product discovery and open new doors for chemists. Pharmaceutical companies already are retraining and hiring chemists who can understand parallel processing, perform solid-state drug synthesis, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Kathryn Brown

    This person does not yet have a bio.

Published In

Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD
The Scientist Placeholder Image

Streamlining Microbial Quality Control Testing

MicroQuant™ by ATCC logo

Products

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

waters-logo

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis